Inactive
Notice ID:36E79723R0019
The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0019 for an unrestrictive procurement for Gabapentin Tablets, for the Department of Veterans Affairs (VA), Depar...
The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0019 for an unrestrictive procurement for Gabapentin Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79723R0019 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 28th, 2023, with a tentative closing date of July 13th, 2023. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Anthony Di Crescenzo. Questions can be emailed to: anthony.dicrescenzo@va.gov. Note that Line items 1 and 3 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e., 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.  The estimated annual requirements are as follows:  ITEM DESCRIPTION PACKAGE SIZE (TABLETS PER BOTTLE) TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 1 Gabapentin 600MG TAB 90 273,678 2 Gabapentin 600MG TAB 500 132,695 3 Gabapentin 800MG TAB 90 83,247 4 Gabapentin 800MG TAB 500 39,761 Â
